XTX Topco Ltd Acquires Shares of 35,447 Anheuser-Busch InBev SA/NV (NYSE:BUD)

XTX Topco Ltd bought a new stake in Anheuser-Busch InBev SA/NV (NYSE:BUD - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 35,447 shares of the consumer goods maker's stock, valued at approximately $1,775,000.

Other hedge funds have also recently modified their holdings of the company. R Squared Ltd acquired a new stake in shares of Anheuser-Busch InBev SA/NV during the fourth quarter worth about $30,000. Rakuten Securities Inc. grew its stake in Anheuser-Busch InBev SA/NV by 2,722.7% during the 4th quarter. Rakuten Securities Inc. now owns 621 shares of the consumer goods maker's stock worth $31,000 after buying an additional 599 shares during the last quarter. Whipplewood Advisors LLC purchased a new stake in Anheuser-Busch InBev SA/NV in the fourth quarter valued at approximately $36,000. Empowered Funds LLC purchased a new position in shares of Anheuser-Busch InBev SA/NV during the fourth quarter worth approximately $49,000. Finally, Hurley Capital LLC acquired a new position in shares of Anheuser-Busch InBev SA/NV in the 4th quarter valued at $49,000. 5.53% of the stock is owned by hedge funds and other institutional investors.

Anheuser-Busch InBev SA/NV Price Performance

NYSE:BUD traded up $0.91 during mid-day trading on Friday, hitting $65.55. 3,321,557 shares of the company's stock traded hands, compared to its average volume of 1,870,358. The firm's 50 day simple moving average is $60.23 and its 200 day simple moving average is $56.66. The company has a market cap of $117.80 billion, a PE ratio of 20.23, a price-to-earnings-growth ratio of 1.73 and a beta of 0.80. Anheuser-Busch InBev SA/NV has a 1 year low of $45.94 and a 1 year high of $67.49. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.51 and a current ratio of 0.69.

Anheuser-Busch InBev SA/NV (NYSE:BUD - Get Free Report) last announced its earnings results on Wednesday, February 26th. The consumer goods maker reported $0.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.75 by $0.13. The firm had revenue of $14.84 billion for the quarter, compared to analyst estimates of $14.07 billion. Anheuser-Busch InBev SA/NV had a net margin of 10.98% and a return on equity of 15.29%. Sell-side analysts expect that Anheuser-Busch InBev SA/NV will post 3.37 EPS for the current year.

Analysts Set New Price Targets

BUD has been the subject of several analyst reports. Argus raised Anheuser-Busch InBev SA/NV from a "hold" rating to a "buy" rating and set a $70.00 price objective for the company in a research note on Thursday, March 27th. StockNews.com lowered Anheuser-Busch InBev SA/NV from a "buy" rating to a "hold" rating in a report on Wednesday. Berenberg Bank began coverage on Anheuser-Busch InBev SA/NV in a research note on Wednesday, April 2nd. They set a "buy" rating for the company. TD Cowen dropped their price objective on Anheuser-Busch InBev SA/NV from $65.00 to $55.00 and set a "hold" rating on the stock in a report on Wednesday, January 8th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Anheuser-Busch InBev SA/NV from a "hold" rating to a "buy" rating in a research report on Monday, March 3rd. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $66.00.

Anheuser-Busch InBev SA/NV Company Profile

Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands.